Bone Drug Data: a new study finds drug of Amgen Xgeva can help to delay the spread of cancer of the prostate for bones per month 4.2, Dow Jones Newswires reports. The drug is already approved for use in some cancer patients whose disease has already spread to bones and a lower dose and carrying Prolia, to prevent osteoporosis. A spokesperson for Amgen tells DJN is not yet clear whether these new data are sufficient to produce for approval by the FDA for the additional use.
Fragmented care: a study published in the archives of Internal Medicine shows that nearly one-third of the adult which is several Massachusetts visits departments visited more than emergency hospital, new health Kaiser reports. That kind of fragmented care can lead to duplicate testing, errors, adverse events and higher costs, study suggests.
Examination of treatments: four treatments used against various types of cardiovascular problems seem not to work particularly well according to recent studies, reports WSJ. A procedure called a PFO Closure, to protect the kidneys of dye used in cardiac imaging, double-determination of Plavix prevent heart stent patients and all contrast acetylcysteine daily monitoring to prevent readmissions heart failure patients have all failed show an advantage, says the paper.
Safety Committee: today marks the first meeting of a Committee established by the Institute of medicine review possible security issues associated with electronic medical records and other computer health, the New York Times reported. David Blumenthal, health administration Obama IT point person, says paper that experts agree to electronic documents ultimately improve safety systems are changed, there are potential risks that they are implemented.
Image: courtesy
No comments:
Post a Comment